Related medicinesMetreleptin
Where it comes from
- Made in
- White fat cells, in proportion to their fat content; also placenta and stomach
- Sent out by
- Steady, with a night-time rise; falls fast with fasting, long before fat is lost
- Acts on
- Hypothalamus (arcuate nucleus: NPY/AgRP and POMC neurons)
- Brainstem
- Immune cells
- Reproductive axis
What it does
- Tells the brain the body is fed: it suppresses hunger and allows puberty, fertility and thyroid output
- Its fall in starvation is the signal that shuts those down
- High in obesity, where the brain stops responding (leptin resistance); it was found by positional cloning of the mouse obese gene in 1994 1
In medicine
- Metreleptin, recombinant leptin, has been approved since 2014 for generalised lipodystrophy, where there is almost no fat and so almost no leptin 2
- Children with congenital leptin deficiency, a very rare condition, lose their extreme obesity on it, and their hunger falls within days 4
- In ordinary obesity leptin injections disappointed: a 1999 trial found modest, highly variable weight loss that rose with dose, and the use was not pursued 3
Beyond the body’s own use
- Leptin is studied to prevent weight regain after dieting, when its level drops, and small trials have restored periods in hypothalamic amenorrhoea; neither is an approved use
- Claims for “leptin supplements” rest on nothing: leptin is a protein and is digested when swallowed, and no leptin product is approved for ordinary weight loss 3
Sources
- Zhang et al., Positional cloning of the mouse obese gene and its human homologue, Nature 1994
- Metreleptin (Myalept), FDA application BLA 125390
- Heymsfield et al., Recombinant leptin for weight loss in obese and lean adults, JAMA 1999
- Farooqi et al., Recombinant leptin therapy in a child with congenital leptin deficiency, New England Journal of Medicine 1999
This card describes what a medicine is for and what the evidence says; it recommends nothing. Talk to your clinician about anything you read here.